Skip to content

Bone health in children with congenital adrenal hyperplasia

Markers of bone mineral metabolism in children and adolescents with congenital adrenal hyperplasia - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/08/071947
Enrollment
30
Registered
2024-08-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E250- Congenital adrenogenital disordersassociated with enzyme deficiency

Interventions

Intervention1: NIL: NIL

Sponsors

Maulana Azad Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of Congenital adrenal hyperplasia aged 5-18 years

Exclusion criteria

Exclusion criteria: Patients with inherent bone conditions

Design outcomes

Primary

MeasureTime frame
To measure markers of bone mineral metabolism Calcium, Phosphate, Alkaline Phosphatase, Vitamin D, Parathyroid Hormone (PTH) and Osteocalcin in patients with Congenital Adrenal Hyperplasia in children and adolescents aged 5-18 yearsTimepoint: To measure markers of bone mineral metabolism Calcium, Phosphate, Alkaline Phosphatase, Vitamin D, Parathyroid Hormone (PTH) and Osteocalcin in patients with Congenital Adrenal Hyperplasia in children and adolescents aged 5-18 years who are already on steroids since birth on follow up stat sample taken on Day 1

Secondary

MeasureTime frame
In children with Congenital Adrenal Hyperplasia 1. To evaluate the association of these markers with projected adult height 2. To study the association of these markers with duration, dose and type of steroids 3. To correlate the levels of these markers with Tanner Staging in age group of 9-18 yearsTimepoint: Baseline

Countries

India

Contacts

Public ContactDr Seema Kapoor

Maulana Azad Medical College

drseemakapoor@gmail.com9868846606

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026